Evidence map›Paper›PMID 32953405›Full record

ArticleBalkan journal of medical genetics : BJMG2020

Relationship between Chromosomal Aberrations and Gene Expressions in the p53 Pathway in Chronic Lymphocytic Leukemia.

G Öztan, M Aktan, S Palanduz, H İşsever, S Öztürk, E Nikerel, A Uçur, G Bağatir, A Bayrak, K Çefle

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

G ÖztanDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
M AktanDepartment of Internal Medicine, Division of Hematology, İstanbul University Faculty of Medicine, İstanbul, Turkey.
S PalanduzDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
H İşseverDepartment of Public Health, İstanbul University Faculty of Medicine, İstanbul, Turkey.
S ÖztürkDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
E NikerelDepartment of Genetics and Bioengineering, Yeditepe University, İstanbul, Turkey.
A UçurDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
G BağatirDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
A BayrakDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
K ÇefleDivision of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, İstanbul, Turkey.
Istanbul University · TRYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) is a neoplasm characterized by excessive accumulation of B lymphocytes in the peripheral blood, bone marrow and lymph nodes. We assessed the expressions of 22 genes in the p53 pathway in 30 CLL patients and 15 healthy subjects by a RT2 Profiler PCR (polymerase chain reaction) Array technique and their relation to cytogenetic aberrations detected by fluorescent

Indexed as

Chronic lymphocytic leukemia (CLL)gene expressionp53 PathwayPrognosisRT2 Profiler PCR (polymerase chain reaction)Array

Identifiers

PMID32953405
PMCPMC7474212
OpenAlexW3081557377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.